4.82
2.77%
0.13
Handel nachbörslich:
4.81
-0.01
-0.21%
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Ardelyx: A Small Bet Its Latest Setback Will Be Temporary (NASDAQ:ARDX) - Seeking Alpha
Ardelyx stock hits 52-week low at $4.34 amid market challenges - Investing.com Canada
Ardelyx (NASDAQ:ARDX) Sets New 1-Year LowShould You Sell? - MarketBeat
Ardelyx (NASDAQ:ARDX) Shares Down 6.5%Here's What Happened - MarketBeat
State Street Corp Acquires 176,789 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - The Eastern Progress Online
Ardelyx, Inc. (NASDAQ:ARDX): Is Breakeven Near? - Yahoo Finance
Ardelyx (ARDX) Sees Its Depressed Stock Turning Around - TipRanks
Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - The Eastern Progress Online
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineARDX - The Eastern Progress Online
ARDX LAWSUIT ALERT: The Gross Law Firm Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - The Eastern Progress Online
Ardelyx, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts against Ardelyx, Inc - The Eastern Progress Online
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Ardelyx CEO Michael Raab sells $131,620 in stock By Investing.com - Investing.com South Africa
Ardelyx CEO Michael Raab sells $131,620 in stock - Investing.com India
Ardelyx, Inc. (NASDAQ:ARDX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - The Eastern Progress Online
Faruqi & Faruqi Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - The Eastern Progress Online
Objective long/short (ARDX) Report - Stock Traders Daily
Hyperphosphatemia Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Ardelyx, Shield Therapeutics, Kyowa Kirin Co., Ltd., Shanghai Alebund Pharma, Sanofi, Bayer, Keryx - The Globe and Mail
Ardelyx, Inc. (NASDAQ:ARDX): Are Analysts Optimistic? - Simply Wall St
BNP Paribas Financial Markets Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
Ardelyx, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsCXM - The Eastern Progress Online
Ardelyx FY2027 EPS Estimate Increased by Leerink Partnrs - MarketBeat
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - The Eastern Progress Online
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):